Company Search:
Advanced Search
Sponsored Links
Kadmon Holdings Inc Company Snapshot
Kadmon Holdings Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Kadmon Holdings Inc with three other companies in this sector in the United States: Syndax Pharmaceuticals Inc (2018 sales of $1.52 million of which 100% was Pharmaceutical), Emmaus Life Sciences Inc ($1.32 million ), and Onconova Therapeutics Inc ($1.23 million ).

Sales Analysis. Sales fell dramatically in 2018: Kadmon Holdings Inc reported sales of $1.40 million for the year ending December of 2018. This represents a sharp decrease of 88.6% versus 2017, when the company's sales were $12.26 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Kadmon Holdings Inc
  Stock Performance Chart for Kadmon Holdings Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/24/2020): 4.47
(Figures in U.S. Dollars)
1 Week -1.5%   13 Weeks -6.5%  
4 Weeks 41.9%   52 Weeks 91.8%  
Kadmon Holdings Inc Key Data:
  Ticker: KDMN Country: United States
  Exchanges: NYSE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 1,396,000
(Year Ending Jan 2019).
Employees: 116
  Currency: U.S. Dollars Market Cap: 579,466,394
  Fiscal Yr Ends: December Shares Outstanding: 129,634,540
  Share Type: Common Closely Held Shares: 550,254
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.